Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Tax Provisions: 2009-2025

Historic Tax Provisions for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $26.9 million.

  • Prestige Consumer Healthcare's Tax Provisions rose 55.74% to $26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.2 million, marking a year-over-year increase of 37.96%. This contributed to the annual value of $69.6 million for FY2025, which is 4.35% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Tax Provisions stood at $26.9 million for Q3 2025, which was up 88.12% from $14.3 million recorded in Q2 2025.
  • Prestige Consumer Healthcare's 5-year Tax Provisions high stood at $26.9 million for Q3 2025, and its period low was -$59.0 million during Q1 2023.
  • For the 3-year period, Prestige Consumer Healthcare's Tax Provisions averaged around $10.8 million, with its median value being $16.9 million (2023).
  • In the last 5 years, Prestige Consumer Healthcare's Tax Provisions crashed by 764.15% in 2023 and then spiked by 130.29% in 2024.
  • Prestige Consumer Healthcare's Tax Provisions (Quarterly) stood at $15.3 million in 2021, then grew by 5.81% to $16.2 million in 2022, then climbed by 2.25% to $16.5 million in 2023, then increased by 15.69% to $19.1 million in 2024, then spiked by 55.74% to $26.9 million in 2025.
  • Its Tax Provisions stands at $26.9 million for Q3 2025, versus $14.3 million for Q2 2025 and $23.8 million for Q1 2025.